Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Teva Pharmaceutical Indus...

    NYSE: TEVA · Real-Time Price · USD
    17.50
    0.51 (3.00%)
    At close: Jun 16, 2025, 3:59 PM

    Teva Pharmaceutical Industries Statistics

    Share Statistics

    Teva Pharmaceutical Industries has 1.15B shares outstanding. The number of shares has increased by 1.17% in one year.

    Shares Outstanding

    n/a
    		 1.15B

    Shares Change (YoY)

    n/a
    		 1.17%

    Shares Change (QoQ)

    n/a
    		 0.99%

    Owned by Institutions (%)

    n/a
    		 58.74%

    Shares Floating

    n/a
    		 1.15B

    Failed to Deliver (FTD) Shares

    n/a
    		 1,934

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 35.67M, so 3.11% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 35.67M

    Short % of Shares Out

    n/a
    		 3.11%

    Short % of Float

    n/a
    		 3.13%

    Short Ratio (days to cover)

    n/a
    		 3.22

    Valuation Ratios

    The PE ratio is -15.21 and the forward PE ratio is 6.2. Teva Pharmaceutical Industries's PEG ratio is -0.08.

    PE Ratio

    n/a
    		 -15.21

    Forward PE

    n/a
    		 6.2

    PS Ratio

    n/a
    		 1.51

    Forward PS

    n/a
    		 1.2

    PB Ratio

    n/a
    		 4.63

    P/FCF Ratio

    n/a
    		 33.28

    PEG Ratio

    n/a
    		 -0.08
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Teva Pharmaceutical Industries.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.98, with a Debt / Equity ratio of 3.36.

    Current Ratio

    n/a
    		 0.98

    Quick Ratio

    n/a
    		 0.75

    Debt / Equity

    n/a
    		 3.36

    Debt / EBITDA

    n/a
    		 25.25

    Debt / FCF

    n/a
    		 24.14

    Interest Coverage

    n/a
    		 -0.3

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $447,135.14

    Profits Per Employee

    n/a
    		 $-44,297.3

    Employee Count

    n/a
    		 37,000

    Asset Turnover

    n/a
    		 0.42

    Inventory Turnover

    n/a
    		 2.82

    Taxes

    Income Tax

    n/a
    		 676M

    Effective Tax Rate

    n/a
    		 -52.65%

    Stock Price Statistics

    The stock price has increased by 2.22% in the last 52 weeks. The beta is 0.61, so Teva Pharmaceutical Industries's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.61

    52-Week Price Change

    n/a
    		 2.22%

    50-Day Moving Average

    n/a
    		 16.06

    200-Day Moving Average

    n/a
    		 17.5

    Relative Strength Index (RSI)

    n/a
    		 53.65

    Average Volume (20 Days)

    n/a
    		 12,087,484

    Income Statement

    In the last 12 months, Teva Pharmaceutical Industries had revenue of 16.54B and earned -1.64B in profits. Earnings per share was -1.45.

    Revenue

    n/a
    		 16.54B

    Gross Profit

    n/a
    		 8.06B

    Operating Income

    n/a
    		 -303M

    Net Income

    n/a
    		 -1.64B

    EBITDA

    n/a
    		 716M

    EBIT

    n/a
    		 -282M

    Earnings Per Share (EPS)

    n/a
    		 -1.45
    Full Income Statement

    Balance Sheet

    The company has 3.3B in cash and 18.08B in debt, giving a net cash position of -14.78B.

    Cash & Cash Equivalents

    n/a
    		 3.3B

    Total Debt

    n/a
    		 18.08B

    Net Cash

    n/a
    		 -14.78B

    Retained Earnings

    n/a
    		 -15.17B

    Total Assets

    n/a
    		 38.41B

    Working Capital

    n/a
    		 371M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 1.25B and capital expenditures -498M, giving a free cash flow of 749M.

    Operating Cash Flow

    n/a
    		 1.25B

    Capital Expenditures

    n/a
    		 -498M

    Free Cash Flow

    n/a
    		 749M

    FCF Per Share

    n/a
    		 0.66
    Full Cash Flow Statement

    Margins

    Gross margin is 48.74%, with operating and profit margins of -1.83% and -9.91%.

    Gross Margin

    n/a
    		 48.74%

    Operating Margin

    n/a
    		 -1.83%

    Pretax Margin

    n/a
    		 -7.76%

    Profit Margin

    n/a
    		 -9.91%

    EBITDA Margin

    n/a
    		 4.33%

    EBIT Margin

    n/a
    		 -1.83%

    FCF Margin

    n/a
    		 4.53%

    Dividends & Yields

    TEVA pays an annual dividend of $1.19, which amounts to a dividend yield of 5.8%.

    Dividend Per Share

    n/a
    		 $1.19

    Dividend Yield

    n/a
    		 5.8%

    Dividend Growth (YoY)

    n/a
    		 0%

    Payout Ratio

    n/a
    		 -106.25%

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for TEVA is $24.5, which is 40% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $24.5

    Price Target Difference

    n/a
    		 40%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 1, 2004. It was a forward split with a ratio of 2:1.

    Last Split Date

    n/a
    		 Jul 1, 2004

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 2:1

    Scores

    Altman Z-Score

    n/a
    		 0.3

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist